Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testos...
Aug 18, 2025, 8:30 AM EDT - 3 days ago
Aug 14, 2025, 8:00 AM EDT - 7 days ago
Aug 13, 2025, 9:10 AM EDT - 8 days ago
Jul 31, 2025, 8:30 AM EDT - 21 days ago
Jul 30, 2025, 7:45 PM EDT - 21 days ago
Jul 22, 2025, 10:45 AM EDT - 4 weeks ago
Jul 9, 2025, 8:30 AM EDT - 6 weeks ago
Jun 24, 2025, 8:30 AM EDT - 2 months ago
Jun 10, 2025, 8:30 AM EDT - 2 months ago
May 28, 2025, 8:30 AM EDT - 3 months ago
May 20, 2025, 8:30 AM EDT - 3 months ago
May 8, 2025, 8:00 AM EDT - 3 months ago
Apr 29, 2025, 8:30 AM EDT - 4 months ago
Apr 14, 2025, 8:30 AM EDT - 4 months ago
Apr 11, 2025, 8:30 AM EDT - 4 months ago
Apr 9, 2025, 8:30 AM EDT - 4 months ago
Mar 20, 2025, 8:30 AM EDT - 5 months ago
Mar 13, 2025, 8:30 AM EDT - 5 months ago
Mar 11, 2025, 8:00 AM EDT - 5 months ago
Mar 3, 2025, 7:30 AM EST - 6 months ago
Feb 25, 2025, 7:30 AM EST - 6 months ago
Feb 20, 2025, 6:15 PM EST - 6 months ago